BCX
BIOCELTIX GPW LISTED

Shareholders

as of September 20, 2026 · source: notifications under Art. 69 of the Offering Act · 4 entities above 5%

FREE FLOAT
62.19%
3,440,600 shares
LARGEST STAKE
14.02%
Towarzystwo Funduszy Inwestycyjnych PZU Spółka Akcyjna
TOP 3 CONCENTRATION
31.2%
3 entities above 5%
LATEST CHANGE
July 16, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · share count normalized to 5,532,253 shares outstanding
SHAREHOLDERS ≥5% 37.81% FREE FLOAT 62.19%
Towarzystwo Funduszy Inwestycyjnych PZU Spółka Akcyjna 14.02%
775,437 shares · notification August 16, 2026
TOTAL Fundusz Inwestycyjny Zamknięty 8.67%
479,500 shares · notification August 16, 2026
Kvarko Group ASI Sp. z o.o. 8.51%
470,953 shares · notification August 16, 2026
Łukasz Bzdzion 6.61%
365,763 shares · notification August 16, 2026
FREE FLOAT — BELOW 5% THRESHOLD
Alternative Solution ASI S.A. 2.47%
— · notification July 16, 2026
Government of Norway 2.44%
— · notification July 16, 2026
Other 57.28%
3,440,600 shares · composition undisclosed

Capital and votes

Number of shares
5,532,253
ISIN
PLBCLTX00019
Sector
Biotechnologia
Market
GPW
Country
PL
Listing date
November 01, 2021

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.